List view / Grid view
27 August 2015 | By Nick Jackson
New treatment option for patients with difficult-to-treat form of skin cancer has shown improved treatment outcomes...
26 August 2015 | By Victoria White
The US Food and Drug Administration (FDA) has approved Praluent (alirocumab) Injection - the first and only PCSK9 inhibitor approved in the US...
26 August 2015 | By Victoria White
Alvogen is to acquire four pharmaceutical products from Pfizer, strengthening Alvogen’s commercial platform in the US market...
26 August 2015 | By Victoria White
Alliance Foundation Trials, the Austrian Breast & Colorectal Cancer Study Group and Pfizer have launched the Palbociclib Collaborative Adjuvant Study...
26 August 2015 | By Victoria White
NICE has recommended Vedolizumab, the first gut-selective treatment for Crohn's Disease, for use on the NHS, recognising the innovation of the treatment...
26 August 2015 | By Victoria White
NICE has recommended once-daily edoxaban for the treatment and prevention of recurrent DVT and pulmonary embolism, saying the drug is cost-effective for the NHS...
25 August 2015 | By CI Precision
Perrigo UK recently installed three SP-4C tablet and capsule sample weight checkers from specialist weighing equipment manufacturer CI Precision...
25 August 2015 | By Victoria White
A large clinical trial by researchers at the National Institutes of Health has found that omega-3 supplements did not slow cognitive decline in older people...
25 August 2015 | By Victoria White
Brazil's pharmaceutical market will expand to reach approximately $47.9 billion by 2020, according to research and consulting firm GlobalData...
25 August 2015 | By Victoria White
The FDA has approved a label expansion for Promacta to treat low blood platelet count in paediatric patients with chronic immune thrombocytopenic purpura...
25 August 2015 | By Victoria White
Novo Nordisk has announced headline results from the final Phase 3a trial with liraglutide as adjunct therapy to insulin for people with type 1 diabetes...
24 August 2015 | By Victoria White
New data from Abbott's Concussion IQ Survey reveals that many adults lack basic understanding about concussion signs, symptoms, risk and treatment...
24 August 2015 | By Victoria White
Phase III study results for Eisai’s Fycompa® (perampanel) in primary generalised tonic-clonic (PGTC) seizures have been published for the first time...
24 August 2015 | By Victoria White
ETNA registries have commenced in Europe to collect a robust set of information on how once-daily edoxaban is being used in real world settings...
24 August 2015 | By Victoria White
AstraZeneca and Peregrine Pharmaceuticals are to evaluate the safety and efficacy of Peregrine’s bavituximab in combination with AstraZeneca’s durvalumab...
